Ranibizumab BS intravitreal injection kit 10mg/mL “Senju”

Ranibizumab BS intravitreal injection kit 10mg/mL “Senju”, from Senju Pharmaceutical, contains ranibizumab (genetical recombination) and is used for macular edema following retinal vein occlusion and age-related macular degeneration with subfoveal choroidal neovascularization. This 0.5mg 0.05mL 1 cylinder formulation (YJ code: 1319407G1029) is a biosimilar VEGF-A antagonist that inhibits abnormal blood vessel growth and leakage in the eye, aiming to improve vision.